Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease
Public ClinicalTrials.gov record NCT00740103. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Long-term Study of Semapimod (CNI-1493) for Treatment of Moderate to Severe Crohn's Disease With Reference to Study CNI-1493-CD-04, 1 or 3 Days' Treatment vs. Placebo
Study identification
- NCT ID
- NCT00740103
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Enrollment
- 119 participants
Conditions and interventions
Conditions
Interventions
- Semapimod Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2002
- Primary completion
- Jun 30, 2004
- Completion
- Aug 31, 2004
- Last update posted
- Mar 27, 2025
2002 – 2004
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94115 | — |
| Atlanta Gastroenterology Associates | Atlanta | Georgia | 30342 | — |
| Advanced Gastroenterology Associates | Suwanee | Georgia | 30024 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Long Island Clinical Research Associates | Great Neck | New York | 11021 | — |
| Asher Kornbluth, MD | New York | New York | 10128 | — |
| Rochester General Hospital | Rochester | New York | 14621 | — |
| Gastroenterology Associates | Bristol | Tennessee | 37620 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00740103, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 27, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00740103 live on ClinicalTrials.gov.